AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 93 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $47,000 | -52.0% | 55,426 | -61.8% | 0.00% | – |
| Q2 2019 | $98,000 | +22.5% | 145,252 | +408.8% | 0.00% | – |
| Q4 2017 | $80,000 | +56.9% | 28,547 | +103.8% | 0.00% | – |
| Q3 2017 | $51,000 | -72.3% | 14,007 | -83.1% | 0.00% | -100.0% |
| Q2 2017 | $184,000 | +68.8% | 82,686 | +9.6% | 0.00% | 0.0% |
| Q1 2015 | $109,000 | – | 75,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |